生命科学资讯

Qilu programs path into cardiometabolic disease with $120M, AI-enabled Insilico alliance

Illumina, Inc. $ILMN Shares Sold by Mitsubishi UFJ Trust & Banking Corp - MarketBeat

Is Thermo Fisher Scientific (TMO) Pricing Reflecting Recent Steady Returns And Growth Expectations - simplywall.st

Roche announces positive phase II results for experimental obesity drug - wkzo.com

Compass Wealth Management LLC Buys 16,124 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat

Single-Cell Genome Sequencing Market Is Going to Boom |• 10x Genomics • Illumina - openPR.com

UK-US biotech investor Epidarex raises $145M for fourth fund

The Analyst Verdict: Illumina In The Eyes Of 15 Experts - Benzinga

IRA drug pricing petitions pile up at the Supreme Court

Clinical Ambitions: 10x Expands Beyond Research with Trio of Collaborations - GEN - Genetic Engineering and Biotechnology News

Ex-CytoDyn CEO sentenced to prison, must pay $5.3M restitution as former CRO leader wins new trial

European investment firm Gimv calls it quits on new life science financing

New rules, higher stakes: Biopharma plays the long game in 2026

China’s edge in early-stage drugmaking ‘likely to persist,’ Pitchbook says

Ex-CytoDyn CEO sentenced to 30 months for pump-and-dump scheme

Med-tech gainers and losers for Jan. 19-23, 2026

Catalent plans to close Belgium cell therapy site

Financings for Jan. 26, 2026

In the clinic for Jan. 26, 2026

Other news to note for Jan. 26, 2026